文献速递消化道出血消化内镜

早期视频胶囊内镜与标准诊疗在非呕血性消化道出血处理中的疗效比较:一项随机对照试验(含视频)

A randomized controlled trial comparing efficacy of early video capsule endoscopy with standard of care in the approach to nonhematemesis GI bleeding (with videos).
PubMed 文献 · Gastrointest Endosc · 2018-06-20

该随机对照试验将87例因非呕血性消化道出血入院的患者分为早期胶囊内镜组(42例)和标准诊疗组(45例),早期胶囊内镜组在入院后不久吞服视频胶囊并根据胶囊发现进行进一步内镜评估。早期胶囊内镜组出血源定位率为64.3%,标准诊疗组为31.1%(P < .01),调整后风险比为2.77(95%CI 1.36-5.64)。作者认为,对于因非呕血性消化道出血入院的患者,早期胶囊内镜是检测出血源的安全有效的替代方法。

要点

  • 早期胶囊内镜组出血源定位率64.3%,标准诊疗组31.1%(P < .01)。
  • 早期胶囊内镜组内镜定位出血的调整后风险比为2.77(95%CI 1.36-5.64)。
  • 作者认为早期胶囊内镜是检测非呕血性消化道出血出血源的安全有效替代方法。

核心结论

  • 对于因非呕血性消化道出血入院的患者,早期胶囊内镜是检测出血源的安全有效的替代方法。

研究设计与样本

  • 随机对照试验,纳入87例因非呕血性消化道出血入院的患者,早期胶囊内镜组42例,标准诊疗组45例。
  • 早期胶囊内镜组患者在入院后不久吞服视频胶囊,并根据胶囊发现进行进一步内镜评估。
  • 标准诊疗组患者由主治消化科医生根据临床表现判断,接受内镜评估(即上消化道内镜、胶囊内镜和/或结肠镜检查)以明确出血源。
  • 主要终点为住院期间出血源定位率。

主要发现

  • 早期胶囊内镜组出血源定位率为64.3%,标准诊疗组为31.1%(P < .01)。
  • 早期胶囊内镜组较标准诊疗组内镜定位出血随时间推移的可能性更高(调整后风险比2.77;95%CI 1.36-5.64)。

临床怎么用

  • 作者认为,对于因非呕血性消化道出血入院的患者,早期胶囊内镜是检测出血源的安全有效的替代方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients presenting with nonhematemesis GI bleeding (NHGIB) represent a diagnostic challenge for physicians. We performed a randomized controlled trial to assess the benefits of deployment of a video capsule soon after admission in the management of patients presenting with melena, hematochezia, or severe anemia compared with standard of care management. METHODS: Patients admitted with NHGIB were randomized and placed into 1 of 2 study groups. In the experimental group, patients ingested a video capsule soon after admission to the hospital. These patients had further endoscopic workup based on the findings from the capsule. Patients in the control group underwent endoscopic evaluation (ie, upper endoscopy, capsule endoscopy, and/or colonoscopy) to identify the source of bleeding as directed by the attending gastroenterologist's interpretation of their clinical presentation. The primary endpoint for this study was the rate of localization of bleeding during hospitalization. RESULTS: Eighty-seven patients were included in this study: 45 randomized to the standard of care arm and 42 to the early capsule arm. A bleeding source was localized in 64.3% of the patients in the early capsule arm and in 31.1% of the patients in the standard of care arm (P < .01). The likelihood of endoscopic localization of bleeding over time was greater for patients receiving early capsule endoscopy compared with those in the standard of care arm (adjusted hazard ratio, 2.77; 95% confidence interval, 1.36-5.64). CONCLUSIONS: For patients admitted to the hospital for NHGIB, early capsule endoscopy is a safe and effective alternative for the detection of the source of bleeding. (Clinical trial registration number: NCT02442830.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Marya NB, Jawaid S, Foley A, et al. A randomized controlled trial comparing efficacy of early video capsule endoscopy with standard of care in the approach to nonhematemesis GI bleeding (with videos). Gastrointest Endosc. 2018. PMID: 29935143. doi:10.1016/j.gie.2018.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。